All-cause and Diseases-specific Mortality of High-risk HPV Infection

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

100000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-01

Study Completion Date

2027-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The corresponding prevention strategies and treatment routes of HPV infection can be provided through investigating causes of death due to HPV infection and specialized diseases.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Evaluation of Detection of High Risk HPV in Urine

NCT05210348

Human Papillomavirus Infection Cervical Cancer Human Papilloma Virus +15 more

UNKNOWN

The Standard Management of HPV Infection

NCT03577925

the High-Risk HPV Infection

UNKNOWN

Protective Efficacy of HPV Vaccination After Treatment of HPV Related Diseases

NCT05085093

HPV Vaccination、HPV Related Diseases、Protective Efficacy

UNKNOWN

Third-Generation Nanopore HPV Integration Site for Precise Prediction of Cervical Cancer Prognosis

NCT06644677

Cervical Cancers HPV Testing Nanopore Sequencing +2 more

COMPLETED

Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV

NCT04974424

Uterine Cervical Neoplasm Uterine Cervical Cancer Cervical Cancer

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Anxiety and panic about HPV infection have become common phenomena in tumor screening. Transitional and useless diagnosis and treatment caused by HPV infection are also common, affecting women's physical and mental health and health economic level. If the investigators can understand the causes of death related to HPV infection and specialized diseases, the investigators can provide corresponding prevention strategies and treatment routes from the level of health policies and individual methods and mechanisms, and also alleviate the related panic caused by HPV infection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HPV Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HPV infection

patients with HPV infection

Observation

Intervention Type OTHER

not available-observation study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observation

not available-observation study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Female participate in at least once cervical cancer screening with clear information of HPV DNA test results;
2. Having clear identification (ID number or others) that can be retrieved in the cause of death database.

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes